Radium-223 dichloride (Xofigo, BAY88-8223) [clinicaltrials_resource:7a655814264c9291e203b7082e61a878]
intervention [clinicaltrials_vocabulary:intervention]
Radium-223 dichloride (Xofigo, BAY88-8223) [clinicaltrials_resource:7a655814264c9291e203b7082e61a878]
Bio2RDF identifier
7a655814264c9291e203b7082e61a878
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:7a655814264c9291e203b7082e61a878
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
Radium-223 dichloride 50 kBq/k ...... eparated by 4 weeks intervals.
intervention name [clinicaltrials_vocabulary:intervention-name]
Radium-223 dichloride (Xofigo, BAY88-8223)
other name [clinicaltrials_vocabulary:other-name]
Alpharadin
identifier
clinicaltrials_resource:7a655814264c9291e203b7082e61a878
title
Radium-223 dichloride (Xofigo, BAY88-8223)
@en
type
label
Radium-223 dichloride (Xofigo, ...... 55814264c9291e203b7082e61a878]
@en